Project Grant HT94252510038
Award Date
2/1/25
Completion Date
1/31/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Station, TX 77843, USA
Similar Awards
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
This $1,224,089 Department of Defense Project Grant awarded on September 30, 2023 to Texas A&M University System Health Science Center will fund a 3-year research project titled "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI". The project will be conducted under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research to transform healthcare for Service...
This federal Project Grant award of $1,001,000.00, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the research project "ENDOCANNABINOID MECHANISMS OF POST-TRAUMATIC EPILEPSY" at Texas A&M University System Health Science Center. The award, with a performance period from Sep 30, 2025 to Sep 29, 2028, will fund advanced biomedical research focused on developing innovative treatments and understanding the...
The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
The Department of Defense awarded a $748,784 Project Grant to the University of Texas Health Science Center at Houston (UTHealth) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, will support research to detect and characterize alpha-synuclein aggregates in patients with Alzheimer's disease and related dementias. Through this project, UTHealth, the prime grantee, will conduct specialized laboratory testing, data...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,949,901.00 in funding to the Salisbury Foundation For Research And Education to conduct research on the relationship between blast exposure and cellular senescence in veterans. The award period runs from Sept. 1, 2025 to Aug. 31, 2029. The funded research aims to transform healthcare for military service members and the broader...
The federal Project Grant award of $183,258.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a longitudinal study monitoring cognitive changes in older veterans using telehealth computerized neuropsychological assessments. The research aims to generate innovative, non-pharmacological approaches to addressing neurological disorders and cognitive health challenges specific to veteran populations. The award...
This federal Project Grant award of $293,978 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Illinois to investigate cognition, vascular function, and physical activity in multiple sclerosis. The award, with a performance period from November 1, 2024 to October 31, 2026, supports advanced biomedical research to transform healthcare for military service members and the broader public. The...
The Department of the Army Medical Command awarded a $422,299 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Texas A&M University System Health Science Center (TAMU HSC) on February 1, 2025. The grant supports research aimed at "Inhibiting Renal Lymphatic Expansion to Mitigate Nephrotic Syndrome". TAMU HSC, a prominent academic medical and research institution, will conduct this biomedical research project over a 2-year period, with a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...